国际药学研究杂志
國際藥學研究雜誌
국제약학연구잡지
INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH
2014年
5期
580-584
,共5页
韩春光%杜丽%胡明%孙晓丽%原美茹%刘永学
韓春光%杜麗%鬍明%孫曉麗%原美茹%劉永學
한춘광%두려%호명%손효려%원미여%류영학
白三烯 B4 受体 2%结肠炎%结肠癌
白三烯 B4 受體 2%結腸炎%結腸癌
백삼희 B4 수체 2%결장염%결장암
leukotriene B4 receptor 2%colitis%colon cancer
目的:通过建立结肠炎相关的结肠癌小鼠动物模型,观察白三烯 B4受体2(leukotriene B4 receptor 2,BLT2)在结肠炎向结肠癌转变过程中 mRNA 和蛋白表达的变化。方法建立 ICR 小鼠结肠炎相关的结肠癌模型,实验分为正常组和模型组,其中模型组以第1次给诱导剂作为 d0,分别于给药后2、3、5、7、9、13和18周不同时间点处死小鼠,取结肠组织,HE 染色观察结肠组织病理学变化,免疫组化法检测小鼠结肠组织 BLT2蛋白的表达,实时定量 PCR 检测小鼠结肠组织 BLT2 mRNA 的表达。结果组织病理学观察发现随着时间的增长,小鼠结肠由轻度炎症逐渐加重,向异型增生转变,最后转变为结肠癌。免疫组化结果显示 BLT2蛋白在正常结肠组织中表达很少,而在炎性病变部位高表达,炎细胞颜色深染;在异型性增生与癌细胞中表达不明显,但在癌组织的间充质及管腔中表达极高。与正常对照组相比,建模后2、13和18周小鼠结肠组织中 BLT2 mRNA 的表达增强(P<0.05),3、5、7和9周表达明显增强(P<0.01)。结论本实验成功复制了小鼠结肠炎相关的结肠癌模型。BLT2在结肠炎发展的过程中表现出规律性变化。由此推测,BLT2在结肠炎向结肠癌转变过程可能发挥着重要的作用。
目的:通過建立結腸炎相關的結腸癌小鼠動物模型,觀察白三烯 B4受體2(leukotriene B4 receptor 2,BLT2)在結腸炎嚮結腸癌轉變過程中 mRNA 和蛋白錶達的變化。方法建立 ICR 小鼠結腸炎相關的結腸癌模型,實驗分為正常組和模型組,其中模型組以第1次給誘導劑作為 d0,分彆于給藥後2、3、5、7、9、13和18週不同時間點處死小鼠,取結腸組織,HE 染色觀察結腸組織病理學變化,免疫組化法檢測小鼠結腸組織 BLT2蛋白的錶達,實時定量 PCR 檢測小鼠結腸組織 BLT2 mRNA 的錶達。結果組織病理學觀察髮現隨著時間的增長,小鼠結腸由輕度炎癥逐漸加重,嚮異型增生轉變,最後轉變為結腸癌。免疫組化結果顯示 BLT2蛋白在正常結腸組織中錶達很少,而在炎性病變部位高錶達,炎細胞顏色深染;在異型性增生與癌細胞中錶達不明顯,但在癌組織的間充質及管腔中錶達極高。與正常對照組相比,建模後2、13和18週小鼠結腸組織中 BLT2 mRNA 的錶達增彊(P<0.05),3、5、7和9週錶達明顯增彊(P<0.01)。結論本實驗成功複製瞭小鼠結腸炎相關的結腸癌模型。BLT2在結腸炎髮展的過程中錶現齣規律性變化。由此推測,BLT2在結腸炎嚮結腸癌轉變過程可能髮揮著重要的作用。
목적:통과건립결장염상관적결장암소서동물모형,관찰백삼희 B4수체2(leukotriene B4 receptor 2,BLT2)재결장염향결장암전변과정중 mRNA 화단백표체적변화。방법건립 ICR 소서결장염상관적결장암모형,실험분위정상조화모형조,기중모형조이제1차급유도제작위 d0,분별우급약후2、3、5、7、9、13화18주불동시간점처사소서,취결장조직,HE 염색관찰결장조직병이학변화,면역조화법검측소서결장조직 BLT2단백적표체,실시정량 PCR 검측소서결장조직 BLT2 mRNA 적표체。결과조직병이학관찰발현수착시간적증장,소서결장유경도염증축점가중,향이형증생전변,최후전변위결장암。면역조화결과현시 BLT2단백재정상결장조직중표체흔소,이재염성병변부위고표체,염세포안색심염;재이형성증생여암세포중표체불명현,단재암조직적간충질급관강중표체겁고。여정상대조조상비,건모후2、13화18주소서결장조직중 BLT2 mRNA 적표체증강(P<0.05),3、5、7화9주표체명현증강(P<0.01)。결론본실험성공복제료소서결장염상관적결장암모형。BLT2재결장염발전적과정중표현출규률성변화。유차추측,BLT2재결장염향결장암전변과정가능발휘착중요적작용。
Objective To observe mRNA and protein expression of leukotriene B4(LTB4)receptor 2(BLT2)in mice during the course of development from colitis to colitis-associated cancer. Methods ICR mice were used to establish the animal model of colitis-associated colon cancer and randomly divided into control group and experimental group. We began to administer inducer on d0. Mice were sacrificed at 2,3,5,7,9,13,and 18w,respectively. Histopathological changes in colons were examined. The protein and mRNA expression of BLT2 in colons were measured by immunohistochemical assay and real-time quantitative PCR, respectively. Results Histological study showed that with the extension of time,the lesions of mice colons aggravated,first a mild inflammation,then atypical hyperplasia,and finally to colon cancer. Immunohistochemical staining showed that the expression of BLT2 protein was low in normal colon,but high in inflammatory lesions,especially in inflammatory cells. There was no BLT2 expression in atypical hyperplasia and cancer cells,while BLT2 was highly expressed in the stroma and lumans of cancer tissue. Compared with the control group,mRNA expression of BLT2 in the experimental group was significantly higher at 2,13 and 18w(P<0.05);and very significantly higher at 3,5,7 and 9w (P<0.01). Conclusion The mouse model of colitis-associated colon cancer was developed in this study. The expression of BLT2 changed in the course of colitis development,indicating that BLT2 may play an important role in the transition process from colitis to colon cancer.